2m 2m 2m 2m 2m 2m 2m
Galectin (GALT)
NASDAQ
$3.82+$0.06 (+1.70%)
Price as of Oct 02, 2026 4:41 PM EDT- $379.2MMarket Cap
- -11.53%1-Year Change
- BiotechnologyIndustry
Galectin (GALT)
$3.82+$0.06 (+1.70%)
GALT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.76 | ||
Change | -$0.12 (-3.09%) | ||
Open | $3.87 | ||
High | $4.05 | ||
Low | $3.68 | ||
Previous Close | $3.88 | ||
Volume | 327,425 | ||
30-Day Average Volume | 321,813 | ||
1-Week Change | -5.05% | ||
1-Month Change | -9.83% | ||
1-Year Change | -11.53% | ||
3-Year Change | 95.83% | ||
5-Year Change | -1.05% | ||
Fundamentals | |||
Shares Outstanding | 100.8M | ||
Total Assets | $14.8M | ||
Market Cap | $379.2M | ||
Enterprise Value | $365.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$9.1M | ||
Free Cash Flow | -$2.4M | ||
EBIT | -$9.1M | ||
EBITDA | -$9.1M | ||
Net Working Capital | -$137.0M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -40 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -3 | ||
P/E | -27 | ||
PEG | 0 | ||
Price/Free Cash Flow | -155 | ||
Price/Operating Cash Flow | -155 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 03/23/2012 | ||
Earnings & Revenue